• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

RBC Life Sciences Supports Clean Energy by Purchasing Renewable Energy Credits to Offset 100 Percent of Its Electricity Usage

Posted on: Monday, 12 January 2009, 07:10 CST

IRVING, Texas, Jan. 12 /PRNewswire-FirstCall/ -- RBC Life Sciences (OTC Bulletin Board: RBCL), a global provider of proprietary nutritional supplements, wound care and pain management products, is offsetting 100 percent of its electricity usage for two years as part of a company-wide green initiative.

RBC Life Sciences is purchasing 2,561,550 kilowatt hours of renewable energy credits, which will help to avoid more than 3.4 million pounds of carbon dioxide pollution. Over a two-year span, this commitment has an impact comparable to planting more than 14,000 mature trees and avoiding the pollution associated with driving 3.4 million miles in an average car.

RBC Life Sciences has also embarked on other energy-saving initiatives. The company uses recycled paper as cushioning in product shipments, new printer ink technology that will eliminate hundreds of pounds of used printer cartridges and special lighting and printing technologies that drastically reduce energy consumption.

"RBC Life Sciences' commitment to sustainable energy meshes well with the company's focus on providing nutritional supplements and skin care products that highlight natural ingredients," said company President and CEO John W. Price. "This company-wide commitment to reduce our carbon footprint is part of a larger company effort to promote clean energy projects and help America become less dependent on fossil fuels."

RBC Life Sciences is purchasing the renewable energy credits from Renewable Choice Energy, a Colorado-based company that works with the nation's alternative energy sector. Every credit purchased helps fund new renewable energy projects, such as wind farms.

About RBC Life SciencesRBC Life Sciences develops, manufactures and markets high-quality nutritional supplements and personal care products to a growing population of consumers seeking wellness and a healthy lifestyle. Under its MPM Medical Inc. brand, RBC Life Sciences also develops and markets to health care professionals in the United States proprietary prescription and nonprescription products for advanced wound care and pain management. All products are tested for quality assurance in-house, and by outside independent laboratories, to comply with regulations in the U.S. and in more than thirty countries in which the products are distributed. For more information, visit the Company's Web site at www.rbclifesciences.com.

The statements above, other than statements of historical fact, may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.

SOURCE RBC Life Sciences

Source: PR Newswire

More News in this Category